Last checked at 20 Nov 2009 07:00
| (AIM: SAR) | 20 November 2009 |
SAREUM HOLDINGS PLC("Sareum" or the "Company")
Availability of Report & Accounts
The Company announces that the report and accounts for the year ended 30 June 2009 has now been posted to shareholders and is available from the Company's website www.sareum.co.uk.
| Sareum Holdings plc | |
| Tim Mitchell | 01223 497 700 |
| Merchant John East Securities Limited (Nominated Adviser) | |
| Simon Clements/Bidhi Bhoma | 020 7628 2200 |
| Hybridan LLP (Broker) | |
| Claire Noyce/Stephen Austin | 020 3159 5085 |
Notes for editors:
About Sareum Holdings plc
Sareum is a drug discovery company, headquartered in Cambridge UK, that is focused on producing targeted small molecule therapeutics to address unmet medical needs, primarily in cancer.
Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.
Sareum Holdings plc joined the AIM market of the London Stock Exchange in October 2004, trading under the symbol SAR. For further information, please visit www.sareum.co.uk